GENUONE Sciences Inc
GENUONE Sciences Inc., headquartered in South Korea, is a pioneering entity in the biotechnology industry, specialising in innovative solutions for health and wellness. Founded in 2015, the company has rapidly established itself as a leader in the development of advanced biopharmaceuticals and diagnostic tools, focusing on personalised medicine and regenerative therapies. With a commitment to research and development, GENUONE Sciences has achieved significant milestones, including the launch of unique products that leverage cutting-edge technology to enhance patient outcomes. Their core offerings, which include proprietary biomaterials and diagnostic platforms, are distinguished by their efficacy and safety, setting new standards in the market. Recognised for its contributions to the field, GENUONE Sciences continues to expand its operational reach across Asia and beyond, solidifying its position as a key player in the global biotechnology landscape.
DitchCarbon Score
How does GENUONE Sciences Inc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
GENUONE Sciences Inc's score of 6 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
GENUONE Sciences Inc's reported carbon emissions
In 2022, GENUONE Sciences Inc reported total carbon emissions of approximately 13,700,000 kg CO2e, comprising 13,700,000 kg CO2e from Scope 1, 10,852,000 kg CO2e from Scope 2, and 3,088,000 kg CO2e from Scope 3 emissions. This represents a slight increase in Scope 1 emissions from 12,634,000 kg CO2e in 2020 and 12,734,000 kg CO2e in 2021, while Scope 2 emissions have remained constant at 10,852,000 kg CO2e across these years. Scope 3 emissions have also remained stable at 3,088,000 kg CO2e. Despite the lack of specific reduction targets or initiatives disclosed, GENUONE Sciences Inc is committed to addressing its carbon footprint. The company has not outlined any formal climate pledges or science-based targets, indicating a potential area for future development in their sustainability strategy. As a company headquartered in South Korea, GENUONE is positioned within a global context that increasingly prioritises climate action and emissions reduction.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Scope 1 | 12,600,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 10,852,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 3,088,000 | 0,000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
GENUONE Sciences Inc is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
